03:32 AM EDT, 09/15/2025 (MT Newswires) -- Andrew Cheng, Director, President and Chief Executive Officer, on September 10, 2025, sold 31,796 shares in Akero Therapeutics ( AKRO ) for $1,374,665. Following the Form 4 filing with the SEC, Cheng has control over a total of 473,902 common shares of the company, with 473,902 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017025114661/xslF345X05/ownership.xml